GRAPPA 2025 Annual meeting report: session on geographic variations in Psoriatic Arthritis/Psoriasis care and resource limitations

Abstract

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 annual meeting featured a session on geographic variations in psoriasis (PsO) and psoriatic arthritis (PsA) care, integrating patient and clinician perspectives from Kenya, Singapore, the US, Colombia, and Türkiye. Presentations addressed disparities in diagnosis, treatment access, workforce capacity, and patient experiences shaped by socioeconomic and cultural contexts. Regional data revealed underdiagnosis of PsA, urban-rural inequities, and inconsistent use of composite disease activity measures. Economic constraints, health system structure, and cultural factors influenced both clinical outcomes and quality of life. Across regions, common challenges included workforce shortages, high treatment costs, diagnostic delays, and unmet mental health needs. A patient testimony from Kenya highlighted extreme cost barriers to biologics and limited specialist avail- ability. The session underscored the importance of global collaboration to improve access, equity, and cultur- ally informed care for individuals living with PsO and PsA